Role of the interaction between puerarin and the erythrocyte membrane in puerarin-induced hemolysis

Chemico-Biological Interactions

Volumn 192, Issue 3, 2011, Pages 184-192

  Hou, Shao Zhen ^a   Su, Zi Ren ^a   Chen, Shu Xian ^b   Ye, Mu Rong ^a   Huang, Song ^a   Liu, Liang ^c   Zhou, Hua ^c   Lai, Xiao Ping ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Erythrocyte; Hemolysis; Membrane structure; Puerarin injection

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); MEMBRANE PROTEIN; PUERARIN;

ARTICLE; CALCIUM TRANSPORT; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; CYTOLYSIS; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; ANTIOXIDANTS; CELL MEMBRANE; ERYTHROCYTES; HEMOLYSIS; HEMOLYTIC AGENTS; HUMANS; ISOFLAVONES; MEMBRANE PROTEINS; PHYTOESTROGENS; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 79957651266     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2011.03.007     Document Type: Article

References (50)

1. W.M. Keung, O. Lazo, L. Kunze, B.L. Vallee, Potentiation of the bioavailability of daidzin by an extract of Radix puerariae, Proc. Natl. Acad. Sci. USA 93 (1996) 4284-4288. (Pubitemid 26146731)
2. Y.P. Hwang, H.G. Jeong, Mechanism of phytoestrogen puerarin-mediated cytoprotection following oxidative injury: estrogen receptor-dependent upregulation of PI3K/Akt and HO-1, Toxicol. Appl. Pharmcol. 233 (2008) 371-381.
3. S. Cui, C. Zhao, X. Tang, D. Chen, Z. He, Study on the bioavailability of puerarin from Pueraria lobata isoflavone self-microemulsifying drug-delivery systems and tablets in rabbits by liquid chromatography-mass spectrometry, Biomed. Chromatogr. 19 (2005) 375-378.
4. D.Y. Guo, S.L. Chen, D.J. Yang, Pharmacokinetic investigation of suspension and nanopaticles in beagle dogs, Li Shi Zhen Med. Mater. Res. 20 (2009) 197-198.
5. D.Q. Quan, G.X. Xu, X.G. Wu, Studies on preparation and absolute bioavailability of a self-emulsifying system containing puerarin, Chem. Pharm. Bull. (Tokyo) 55 (2007) 800-803.
6. S.D. Liu, H.P. Mo, Occurrence and prevention of adverse reaction induced by puerarin injection, Zhongguo Zhong Xi Yi Jie He Za Zhi 25 (2005) 852-855.
7. T.Y. Xu, B.X. Du, Analysis on the 169 cases of drug adverse reactions induced by puerarin injection, Pract. Pharm. Remed. 10 (2007) 230-231.
8. J.G. Xu, Study on adverse drug reactions and correlation factor induced by puerarin injection during applying, Chin. J. Mod. Drug Appl. 3 (2009) 21-22.
9. P.Y. Deng, L. Zhang, Exploration of safety monitoring of puerarin injection in post-market surveillance ADR signal detection and surveillance, Chin. J. Pharmacovigil. 3 (2008) 136-139.
10. J. Dausset, L. Contu, Drug-induced hemolysis, Annu. Rev. Med. 18 (1967) 55-70.
11. B. Goldberg, A. Stern, Superoxide anion as a mediator of drug-induced oxidative hemolysis, J. Biol. Chem. 251 (1976) 6468-6470.
12. Z.S. Bowman, J.D. Morrow, D.J. Jollow, D.C. McMillan, Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine, J. Pharmacol. Exp. Ther. 314 (2005) 838-845.
13. I.P. Lee, A possible mechanism of ellipticine-induced hemolysis, J. Pharmacol. Exp. Ther. 196 (1976) 525-535.
14. S.M. Cruz, V.M. Madeira, L.M. Almeida, J.B. Custodio, Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure, Biochim. Biophys. Acta 1464 (2000) 49-61.
15. N. Penha-Silva, L.R. Arvelos, C.C. Cunha, T.A. Aversi-Ferreira, L.F. Gouve-Silva, M.S. Garrote-Filho, C.J. Finotti, M. Bernardino-Neto, F.G. Freitas Reis, Effects of glycerol and sorbitol on the thermal dependence of the lysis of human erythrocytes by ethanol, Bioelectrochemistry 73 (2008) 23-29.
16. H. Sheppard, W.H. Tsien, C. Burghardt, Effect of drugs on the hemolysis of rat erythrocytes, Biochem. Pharmacol. 18 (1969) 2215-2223.
17. A. Miura, Drug-induced hemolytic anemia, Nippon. Rinsho. 54 (1996) 2534-2538.
18. P.A. Arndt, Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone - a case study approach, Immunohematology 18 (2002) 27-32. (Pubitemid 34602785)
19. P.Y. Deng, Q.N. Li, Y.Z. Zhu, Z.E. Fei, J. Zhang, W. Zhai, An analysis of adverse drug reactions of puerarin injection and related risk factors, Chin. J. Pharmacol. Epidemiol. 14 (2005) 14-19.
20. S.Z. Hou, G. Li, M.R. Ye, X.P. Lai, Z.R. Su, Experimental studies on mechanism of hemolysis induced by puerarin injection, Adverse Drug React. J. 2 (2008) 1-6.
21. P.F. Yue, Y.H. Long, W.F. Zhu, L.B. Cong, H. Xie, Z.G. Liu, L.J. Wang, X.H. Xiao, The study to reduce the hemolysis side effect of puerarin by a submicron emulsion delivery system, Biol. Pharm. Bull. 31 (2008) 45-50.
22. L. Backman, Shape control in the human red cell, J. Cell. Sci. 80 (1986) 281-298.
23. D. Bratosin, J. Estaquier, F. Petit, D. Arnoult, B. Quatannens, J.P. Tissier, C. Slomianny, C. Sartiaux, C. Alonso, J.J. Huart, J. Montreuil, J.C. Ameisen, Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria, Cell. Death. Differ. 8 (2001) 1143-1156. (Pubitemid 34048470)
24. W.H. Reinhart, S. Chien, Red cell rheology in stomatocyte-echinocyte transformation: roles of cell geometry and cell shape, Blood 67 (1986) 1110-1118. (Pubitemid 16116427)
25. N. Mohandas, J.A. Chasis, Red blood cell deformability, membrane material properties and shape: regulation by transmembrane, skeletal and cytosolic proteins and lipids, Semin. Hematol. 30 (1993) 171-192. (Pubitemid 23216313)
26. T. Fujii, T. Sato, A. Tamura, M. Wakatsuki, Y. Kanaho, Shape changes of human erythrocytes induced by various amphipathic drugs acting on the membrane of the intact cells, Biochem. Pharmacol. 28 (1979) 613-620.
27. S. Chaudhuri, A. Banerjee, K. Basu, B. Sengupta, P.K. Sengupta, Interaction of flavonoids with red blood cell membrane lipids and proteins: antioxidant and antihemolytic effects, Int. J. Biol. Macromol. 41 (2007) 42-48. (Pubitemid 46476807)
28. A.B. Chukhlovin, Apoptosis and red blood cell echinocytosis: common features, Scanning Microsc. 10 (1996) 795-804. (Pubitemid 28498874)
29. D.A. Garcia, S. Quiroga, M.A. Perillo, Flunitrazepam partitioning into natural membranes increases surface curvature and alters cellular morphology, Chem. Biol. Interact. 129 (2000) 263-277. (Pubitemid 32008376)
30. M. Piagnerelli, K.Z. Boudjeltia, D. Brohee, P. Piro, E. Carlier, J.L. Vincent, P. Lejeune, M. Vanhaeverbeek, Alterations of red blood cell shape and sialic acid membrane content in septic patients, Crit. Care Med. 31 (2003) 2156-2162.
31. S. Biswas, J. Bhattacharyya, A.G. Dutta, Oxidant induced injury of erythrocyte - role of green tea leaf and ascorbic acid, Mol. Cell. Biochem. 276 (2005) 205-210. (Pubitemid 41236226)
32. D.A. Andrews, L. Yang, P.S. Low, Phorbol ester stimulates a protein kinase C-mediated agatoxin-TK-sensitive calcium permeability pathway in human red blood cells, Blood 100 (2002) 3392-3399. (Pubitemid 35217092)
33. P.C. Chan, O.G. Peller, L. Kesner, Copper(II)-catalyzed lipid peroxidation in liposomes and erythrocyte membranes, Lipids 17 (1982) 331-337. (Pubitemid 12058256)
34. J.M. Gutteridge, B. Halliwell, Reoxygenation injury and antioxidant protection: a tale of two paradoxes, Arch. Biochem. Biophys. 283 (1990) 223-226.
35. G. Fairbanks, T.L. Steck, D.F. Wallach, Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane, Biochemistry - US 10 (1971) 2606-2617.
36. T.P. Bradshaw, D.C. McMillan, R.K. Crouch, D.J. Jollow, Formation of free radicals and protein mixed disulfides in rat red cells exposed to dapsone hydroxylamine, Radic. Biol. Med. 22 (1997) 1183-1193. (Pubitemid 27171960)
37. M.O. Hengartner, The biochemistry of apoptosis, Nature 407 (6805) (2000) 770-776.
38. H.E. Demey, L.L. Bossaert, Propylene glycol intoxication and nitroglycerin therapy, Crit. Care Med. 15 (5) (1987) 540.
39. H.E. Demey, R.A. Daelemans, G.A. Verpooten, M.E. De Broe, C.M. Van Campenhout, F.V. Lakiere, P.J. Schepens, L.L. Bossaert, Propylene glycol-induced side effects during intravenous nitroglycerin therapy, Intensive Care Med. 14 (3) (1988) 221-226.
40. H.B. Wang, Study on the Hemolytic Toxicity of Puerarin Injection, China Knowledge Resource Integrated Database, Beijing, 2010, pp. 53-54.
41. F. Lin, Y. Xin, J. Wang, L. Ma, J. Liu, C. Liu, L. Long, F. Wang, Y. Jin, J. Zhou, J. Chen, Puerarin facilitates Ca(2+)-induced Ca(2+) release triggered by KCl-depolarization in primary cultured rat hippocampal neurons, Eur. J. Pharmacol. 570 (2007) 43-49.
42. X. Xu, X. Zheng, Potential involvement of calcium and nitric oxide in protective effects of puerarin on oxygen-glucose deprivation in cultured hippocampal neurons, J. Ethnopharmacol. 113 (2007) 421-426. (Pubitemid 47361557)
43. M.P. Sheetz, S.J. Singer, Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions, Proc. Natl. Acad. Sci. USA 71 (1974) 4457-4461.
44. B. Isomaa, H. Hagerstrand, G. Paatero, A.C. Engblom, Permeability alterations and antihaemolysis induced by amphiphiles in human erythrocytes, Biochim. Biophys. Acta 860 (1986) 510-524.
45. A. Saija, F. Bonina, D. Trombetta, A. Tomaino, L. Montenegro, P. Smeriglio, F. Castelli, Flavonoid-bio-membrane interactions: a calorimetric study on dipalmitoylphosphatidylcholine vesicles, Int. J. Pharm. 124 (1995) 1-8.
46. F. Ollila, K. Halling, P. Vuorela, H. Vuorela, J.P. Slotte, Characterization of flavonoid-bio-membrane interactions, Arch. Biochem. Biophys. 399 (2002) 103-108.
47. A. Arora, T.M. Byrem, M.G. Nair, G.M. Strasburg, Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids, Arch. Biochem. Biophys. 373 (2000) 102-109. (Pubitemid 30046494)
48. J.Q. Xi, R. Guo, The interaction between puerarin and lipid encapsulation, Chin. Sci. Bull. 52 (2007) 1997-2002.
49. B. Pawlikowska-Pawlega, W.I. Gruszecki, L.E. Misiak, A. Gawron, The study of the quercetin action on human erythrocyte membranes, Biochem. Pharmacol. 66 (2003) 605-612.
50. J.S. He, Puerarin injection adverse reactions and announcements, Mod. J. Integr. Traditional Chin. West. Med. 16 (2007) 3114-3115.